Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Hypoglycemic Effect Of Biotin-modified Liposomes Loading Insulin: Effect Of Formulation Variables, Intracellular Trafficking, And Cytotoxicity

X. Zhang, J. Qi, Yi Lu, X. Hu, W. He, W. Wu
Published 2014 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Peroral protein/peptide delivery has been one of the most challenging, but encouraging topics in pharmaceutics. This article was intended to explore the potential of biotin-modified liposomes (BLPs) as oral insulin delivery carriers. By incorporating biotin-DSPE into the lipid bilayer, we prepared BLPs using reverse evaporation/sonication method. We investigated hypoglycemic effects in normal rats after oral administration of BLPs, and the possible absorption mechanism by a series of in vitro tests. The relative pharmacological bioavailability of BLPs was up to 11.04% that was as much as 5.28 folds of conventional liposomes (CLPs). The results showed that the enhanced oral absorption of insulin mainly attributed to biotin ligand-mediated endocytosis. The results provided proof of BLPs as effective carriers for oral insulin delivery.
This paper references
Endocrines GT: Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? Clin Endocrinol (Oxf
G Pina (2013)
10.1016/j.ejpb.2010.09.016
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Y. Zhang (2011)
10.2217/NNM.11.116
Bursting the bubble: microbubble–nanoparticle composites for ultrasound-mediated drug delivery.
J. Lovell (2011)
10.1021/bc100093v
A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
E. Lee (2010)
The future of insulin therapy for patients with type 2 diabetes mellitus.
J. Tibaldi (2013)
Pharmacokinetic study of niosome-loaded insulin in diabetic rats
A. Pardakhty (2011)
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT.
V. Yellepeddi (2011)
10.1016/j.ejpb.2010.07.002
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
10.1111/cen.12017
An audit of growth hormone replacement for GH‐deficient adults in Scotland
S. Philip (2013)
10.1016/j.jnutbio.2011.01.003
Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis.
E. Larrieta (2012)
10.1016/S1773-2247(07)50080-8
Enzyme triggered pH sensitive liposomes for insulin delivery
S. Jain (2007)
10.1152/ajpcell.1999.277.4.C605
Molecular mechanism of the intestinal biotin transport process.
N. Chatterjee (1999)
10.2217/nnm.11.116
Biodegradable star polymers shine for cancer drug delivery.
J. Lovell (2011)
Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity
Zhang (2014)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
10.1111/jmp.12025
Human insulin versus porcine insulin in rhesus monkeys with diabetes mellitus
X. Jin (2013)
10.1016/j.biomaterials.2011.08.087
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
M. Chen (2011)
10.1016/j.biomaterials.2012.03.029
Real time observation and kinetic modeling of the cellular uptake and removal of silicon quantum dots.
S. Ohta (2012)
10.2147/IJN.S19917
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation
M. Niu (2011)
10.1021/NL0479987
Super pH-sensitive multifunctional polymeric micelle.
E. Lee (2005)
10.1016/j.addr.2013.01.002
Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
A. des Rieux (2013)
10.4137/DTI.S0
Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery
J.H. Hamman (2007)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1016/J.IJPHARM.2005.01.018
Investigation of lectin-modified insulin liposomes as carriers for oral administration.
N. Zhang (2005)
10.1016/j.ejpb.2010.12.008
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
10.1080/10611860410001693760
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
G. J. Russell-Jones (2004)
10.1166/JNN.2006.416
Oral administration of liposomal insulin.
I. T. Değim (2006)
10.1021/BI00775A029
The phospholipid-cholesterol interaction. Kinetics of water permeability in liposomes.
R. Bittman (1972)
10.1016/J.JCONREL.2006.12.003
A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.
K. Chalasani (2007)
10.1002/anie.200800865
Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs.
Amanda K. Petrus (2009)
10.1016/j.ijpharm.2012.03.056
Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.
M. Rekha (2013)
10.1016/j.addr.2012.09.041
Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
S. Xu (2013)
10.1016/J.EJPS.2006.04.014
Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles.
N. Peppas (2006)
10.1097/MEG.0b013e32835cec52
Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours
S. Murugesan (2013)
10.1016/j.ijpharm.2012.01.034
Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers.
J. Y. Kim (2012)
10.1111/cen.12001
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?
G. Pina (2013)
Nanoscale Research Letters
Zhang (2014)
10.1016/J.EJPB.2007.07.009
Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: design, preparation, and biological evaluation.
Y. Youn (2008)
10.1080/10611860701350099
Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles
Y. Mirochnik (2007)
10.1021/BM0503165
Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles.
M. Francis (2005)



This paper is referenced by
10.1016/J.JDDST.2019.04.035
Challenge for oral delivery of middle-molecular drugs: Use of osmolarity-sensitive liposome as a drug carrier in the GI tract
K. Minami (2020)
10.1016/B978-0-323-42861-3.00014-5
Improved oral bioavailability of bioactives through lipid-based nanoarchitectures**Declaration of Interest: The authors report no conflict of interest.
Udita Agrawal (2016)
10.1016/j.diabres.2017.11.018
Nanotechnology based approaches for anti-diabetic drugs delivery.
P. Kesharwani (2018)
10.1007/978-981-15-4802-4_7
Application of Nanomaterials in the Diagnosis and Treatment of Genetic Disorders
Alaa A A Aljabali (2020)
10.1016/j.jconrel.2020.04.006
Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems.
Yining Xu (2020)
10.3390/molecules24234209
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
E. B. Souto (2019)
10.1016/j.apsb.2017.11.007
Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin
Haisheng He (2018)
10.1016/j.colsurfb.2020.111203
Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies.
Jafar Rahnama Yazdi (2020)
10.1038/s41392-019-0068-3
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Akhand Pratap Singh (2019)
10.1016/J.PMATSCI.2017.05.001
Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
Francisca Araújo (2017)
10.1016/j.jconrel.2016.07.051
Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Amrita Banerjee (2016)
10.2174/1567201817666200512102532
Nanoliposome Precursors for Shape Modulation: Use of Heuristic Algorithm and QBD Principles for Encapsulating phytochemicals.
Sameer J. Nadaf (2020)
10.1039/c4cp03028a
Interaction of insulin with anionic phospholipid (DPPG) vesicles.
B. Tah (2014)
10.1080/14328917.2020.1779168
Studies on formulation development and evaluation of tolnaftate-loaded glycerosomes
Yasmin Begum Mohammed (2020)
10.1016/j.addr.2018.11.008
Therapeutic medications against diabetes: What we have and what we expect.
C. Hu (2018)
10.2174/1389450120666190307101642
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.
A. M. Mohsen (2019)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1208/s12249-019-1363-6
Insulin Mucoadhesive Liposomal Gel for Wound Healing: a Formulation with Sustained Release and Extended Stability Using Quality by Design Approach
Marwa H S Dawoud (2019)
10.1016/j.ijpharm.2018.07.041
Recent advancements in oral administration of insulin‐loaded liposomal drug delivery systems for diabetes mellitus
Chun Y Wong (2018)
Nanotechnology : A Novel Approach for the Treatment of Diabetic Mellitus
Tanmoy Saha (2019)
10.3389/fbioe.2020.00425
Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
Zeinab Nouri (2020)
10.1016/j.apsb.2018.06.005
Adapting liposomes for oral drug delivery
Haisheng He (2019)
Semantic Scholar Logo Some data provided by SemanticScholar